Drug application
PORTRAZZA (NECITUMUMAB)
Drugs@FDA BLA 125547 · ELI LILLY CO
Key facts
| Drug name | PORTRAZZA |
|---|---|
| Active ingredients | NECITUMUMAB |
| Application type | BLA |
| Application number | 125547 |
| Company | ELI LILLY CO |
| Dosage forms | INJECTABLE, INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL |
| Strength | 800MG/50ML |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Nov 24, 2015 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: